Clinical Studies
Where is LVOne being clinically validated?
Our LVOne test is undergoing validation in real-world settings around the globe. These clinical tests and commercial evaluation ensure that LVOne meets the highest standards of safety, accuracy, and clinical impact.
DIAGNOSIS
This study aims to test a new diagnostic tool that combines clinical
Off-shore Germany
Testing LVOne system’s performance and feasibility in the challenging off-s
Newcastle Biobank
Biomarker screening and validation for LVO detection in suspected stroke patients.
Testing for Identification Markers of strokE (TIME) study.
Prospective validation of biomarkers and scales cut-off levels in suspected stroke patients identified by ambulance staff.
Rapid Assay Diagnostic for Acute stroke Recognition (RADAR)
To determine the diagnostic accuracy of the ‘LVOne’ test for identification of large vessel occlusion stroke in prospective suspected stroke patients.
Feasibility study in remote EMS
Feasibility pilot study for use in off-shore facilitiies
PRehospital biomarker and phoNe call-based detection for
ischaemic stroke thrombecTOmy (PRONTO)
Clinical study – Performance evaluation LVOne in Ambulance
Research & Publications
Published Research Supporting LVOne
Explore the peer-reviewed research validating our biomarker approach and its real-world clinical applications.
BMJ Neurology Open
Integrating clinical predictors and GFAP in models for pre-hospital ICH identification
Stroke: Vascular and Interventional Neurology
Detection of GFAP and D-Dimer in a Point-of-Care Test
BMJ Neurology Open
Integrating clinical predictors and GFAP in models for pre-hospital ICH identification
Stroke: Vascular and Interventional Neurology
Detection of GFAP and D-Dimer in a Point-of-Care Test
Become a Distributor of the World’s First Lateral Flow Stroke Test
Download the exclusive LVOne Distributor Dossier to explore our breakthrough stroke diagnostic, its clinical validation, and the commercial opportunity in your region.
